After-hours access available— Naloxone kiosks and ER bridge clinics are open 24/7. See the map below.833-234-6343
Back to blog
Access & Policy
November 2, 2025

The Economics of Addiction: Why Cost Transparency Matters

The economic case for expanding MAT access is overwhelming. Every dollar invested in treatment returns $4–$7 in reduced crime, healthcare costs, and lost productivity. The information gap is solvable.

The economic barriers to addiction treatment are as lethal as the pharmacological ones. A patient with opioid use disorder who cannot access affordable medication has effectively been denied treatment by the market. The financial burden of chronic disease management — particularly for people rebuilding their lives on modest incomes — can be the difference between staying in treatment and dropping out entirely.

The Information Gap Problem

The information gap compounds the access problem. Many patients on buprenorphine are not aware of the full range of financial assistance programs available to them — Medicaid coverage, state-funded treatment slots, sliding-scale fees, and pharmaceutical patient assistance programs. Providers often lack the time or awareness to navigate these options with their patients. The result is preventable treatment dropout.

Addressing the cost barrier requires systemic solutions: expanded Medicaid coverage, state block grant funding for treatment, and advocacy for parity enforcement. Live Now Recovery supports patients in finding providers who offer financially accessible treatment options, because keeping someone in treatment saves lives and saves money — $4 to $7 returned for every $1 invested.

The Broader Economic Case

The broader economics of addiction treatment illustrate why the cost transparency argument extends beyond individual patients. Every dollar invested in MAT yields an estimated $4 to $7 in reduced drug-related crime, criminal justice costs, and healthcare costs — and some estimates put the return higher when long-term productivity gains are included. The economic case for expanding access to affordable MAT is not a social justice argument dressed in numbers — it's a straightforward cost-benefit analysis. Solving the information and cost barriers is not charitable; it's fiscally rational. Live Now Recovery exists at the intersection of those two arguments.

We use essential cookies to keep this platform working. We never track patients or collect health data. Privacy Policy

Manage Cookies